Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Samantha J. L. Knight is active.

Publication


Featured researches published by Samantha J. L. Knight.


The New England Journal of Medicine | 2008

Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes

Mefford Hc; Andrew J. Sharp; Carl Baker; Andy Itsara; Zhaoshi Jiang; Karen Buysse; Shuwen Huang; Viv Maloney; John A. Crolla; Diana Baralle; Amanda L. Collins; Catherine L. Mercer; Koenraad K. Norga; Thomy de Ravel; Koenraad Devriendt; Ernie M.H.F. Bongers; Nicole de Leeuw; William Reardon; Stefania Gimelli; Frédérique Béna; Raoul C. M. Hennekam; Alison Male; Lorraine Gaunt; Jill Clayton-Smith; Ingrid Simonic; Soo Mi Park; Sarju G. Mehta; Serena Nik-Zainal; C. Geoffrey Woods; Helen V. Firth

BACKGROUND Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of submicroscopic imbalances in large numbers of patients. METHODS We tested for the presence of microdeletions and microduplications at a specific region of chromosome 1q21.1 in two groups of patients with unexplained mental retardation, autism, or congenital anomalies and in unaffected persons. RESULTS We identified 25 persons with a recurrent 1.35-Mb deletion within 1q21.1 from screening 5218 patients. The microdeletions had arisen de novo in eight patients, were inherited from a mildly affected parent in three patients, were inherited from an apparently unaffected parent in six patients, and were of unknown inheritance in eight patients. The deletion was absent in a series of 4737 control persons (P=1.1x10(-7)). We found considerable variability in the level of phenotypic expression of the microdeletion; phenotypes included mild-to-moderate mental retardation, microcephaly, cardiac abnormalities, and cataracts. The reciprocal duplication was enriched in nine children with mental retardation or autism spectrum disorder and other variable features (P=0.02). We identified three deletions and three duplications of the 1q21.1 region in an independent sample of 788 patients with mental retardation and congenital anomalies. CONCLUSIONS We have identified recurrent molecular lesions that elude syndromic classification and whose disease manifestations must be considered in a broader context of development as opposed to being assigned to a specific disease. Clinical diagnosis in patients with these lesions may be most readily achieved on the basis of genotype rather than phenotype.


Nature Genetics | 2006

Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome

Andrew J. Sharp; Sierra Hansen; Rebecca R. Selzer; Ze Cheng; Regina Regan; Jane Hurst; Helen Stewart; Sue M. Price; Edward Blair; Raoul C. M. Hennekam; Carrie Fitzpatrick; Rick Segraves; Todd Richmond; Cheryl Guiver; Donna G. Albertson; Daniel Pinkel; Peggy S. Eis; Stuart Schwartz; Samantha J. L. Knight; Evan E. Eichler

Genomic disorders are characterized by the presence of flanking segmental duplications that predispose these regions to recurrent rearrangement. Based on the duplication architecture of the genome, we investigated 130 regions that we hypothesized as candidates for previously undescribed genomic disorders. We tested 290 individuals with mental retardation by BAC array comparative genomic hybridization and identified 16 pathogenic rearrangements, including de novo microdeletions of 17q21.31 found in four individuals. Using oligonucleotide arrays, we refined the breakpoints of this microdeletion, defining a 478-kb critical region containing six genes that were deleted in all four individuals. We mapped the breakpoints of this deletion and of four other pathogenic rearrangements in 1q21.1, 15q13, 15q24 and 17q12 to flanking segmental duplications, suggesting that these are also sites of recurrent rearrangement. In common with the 17q21.31 deletion, these breakpoint regions are sites of copy number polymorphism in controls, indicating that these may be inherently unstable genomic regions.


Nature Genetics | 2008

A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures

Andrew J. Sharp; Mefford Hc; Kelly Li; Carl Baker; Cindy Skinner; Roger E. Stevenson; Richard J. Schroer; Francesca Novara; Manuela De Gregori; Roberto Ciccone; Adam Broomer; Iris Casuga; Yu Wang; Chunlin Xiao; Catalin Barbacioru; Giorgio Gimelli; Bernardo Dalla Bernardina; Claudia Torniero; Roberto Giorda; Regina Regan; Victoria Murday; Sahar Mansour; Marco Fichera; Lucia Castiglia; Pinella Failla; Mario Ventura; Zhaoshi Jiang; Gregory M. Cooper; Samantha J. L. Knight; Corrado Romano

We report a recurrent microdeletion syndrome causing mental retardation, epilepsy and variable facial and digital dysmorphisms. We describe nine affected individuals, including six probands: two with de novo deletions, two who inherited the deletion from an affected parent and two with unknown inheritance. The proximal breakpoint of the largest deletion is contiguous with breakpoint 3 (BP3) of the Prader-Willi and Angelman syndrome region, extending 3.95 Mb distally to BP5. A smaller 1.5-Mb deletion has a proximal breakpoint within the larger deletion (BP4) and shares the same distal BP5. This recurrent 1.5-Mb deletion contains six genes, including a candidate gene for epilepsy (CHRNA7) that is probably responsible for the observed seizure phenotype. The BP4–BP5 region undergoes frequent inversion, suggesting a possible link between this inversion polymorphism and recurrent deletion. The frequency of these microdeletions in mental retardation cases is ∼0.3% (6/2,082 tested), a prevalence comparable to that of Williams, Angelman and Prader-Willi syndromes.


Cell | 1993

Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation

Samantha J. L. Knight; Angela V. Flannery; Mark C. Hirst; L. Campbell; Zoe Christodoulou; S.R. Phelps; J. Pointon; H.R. Middleton-Price; Angela Barnicoat; M.E. Pembrey; J. Holland; Ben A. Oostra; M. Bobrow; Kay E. Davies

We have cloned the fragile site FRAXE and demonstrate that individuals with this fragile site possess amplifications of a GCC repeat adjacent to a CpG island in Xq28 of the human X chromosome. Normal individuals have 6-25 copies of the GCC repeat, whereas mentally retarded, FRAXE-positive individuals have > 200 copies and also have methylation at the CpG island. This situation is similar to that seen at the FRAXA locus and is another example in which a trinucleotide repeat expansion is associated with a human genetic disorder. In contrast with the fragile X syndrome, the GCC repeat can expand or contract and is equally unstable when passed through the male or female line. These results also have implications for the understanding of chromosome fragility.


The Lancet | 1999

Subtle chromosomal rearrangements in children with unexplained mental retardation

Samantha J. L. Knight; Regina Regan; Alison Nicod; Sharon W. Horsley; Lyndal Kearney; Tessa Homfray; Robin M. Winter; Patrick Bolton; Jonathan Flint

BACKGROUND No explanation for moderate to severe mental retardation is apparent in about 40% of cases. Although small chromosomal rearrangements may account for some undiagnosed cases, a lack of genome-wide screening methods has made it impossible to ascertain the frequency of such abnormalities. METHODS A fluorescence in-situ hybridisation (FISH) test was used to examine the integrity of chromosome ends in 284 children with unexplained moderate to severe retardation, and in 182 children with unexplained mild retardation. 75 normal men were also tested. When a chromosomal rearrangement was found, its size was estimated, and members of the childs family were investigated. FINDINGS Subtle chromosomal abnormalities occurred with a frequency of 7.4% in the children with moderate to severe mental retardation, and of 0.5% in the children with mild retardation. The abnormalities had an estimated population prevalence of 2.1 per 10,000, and were familial in almost half of cases. INTERPRETATION Once recognisable syndromes have been excluded, abnormalities that include the ends of chromosomes are the commonest cause of mental retardation in children with undiagnosed moderate to severe mental retardation. Owing to the high prevalence of familial cases, screening for subtle chromosomal rearrangements is warranted in children with unexplained moderate to severe mental retardation.


Nature Genetics | 2006

A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism

David A. Koolen; Lisenka E.L.M. Vissers; Rolph Pfundt; Nicole de Leeuw; Samantha J. L. Knight; Regina Regan; R. Frank Kooy; Edwin Reyniers; Corrado Romano; Marco Fichera; Albert Schinzel; Alessandra Baumer; Britt Marie Anderlid; Jacqueline Schoumans; N.V.A.M. Knoers; Ad Geurts van Kessel; Erik A. Sistermans; Joris A. Veltman; Han G. Brunner; Bert B.A. de Vries

Submicroscopic genomic copy number changes have been identified only recently as an important cause of mental retardation. We describe the detection of three interstitial, overlapping 17q21.31 microdeletions in a cohort of 1,200 mentally retarded individuals associated with a clearly recognizable clinical phenotype of mental retardation, hypotonia and a characteristic face. The deletions encompass the MAPT and CRHR1 genes and are associated with a common inversion polymorphism.


Journal of Experimental Medicine | 2011

The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance

Monika Mortensen; Elizabeth J. Soilleux; Gordana Djordjevic; Rebecca Tripp; Michael Lutteropp; Elham Sadighi-Akha; Amanda J. Stranks; Julie Glanville; Samantha J. L. Knight; Sten Eirik W. Jacobsen; Kamil R. Kranc; Anna Katharina Simon

Adult mouse LSK cells unable to undergo autophagy contain fewer HSCs, accumulate mitochondria, and fail to reconstitute lethally irradiated mice.


American Journal of Human Genetics | 2000

An Optimized Set of Human Telomere Clones for Studying Telomere Integrity and Architecture

Samantha J. L. Knight; Christa M. Lese; Kathrin S. Precht; Julie Kuc; Yi Ning; Sarah Lucas; Regina Regan; Mary Brenan; Alison Nicod; N. Martin Lawrie; Donald L.N. Cardy; Huy L. Nguyen; Thomas J. Hudson; Harold Riethman; David H. Ledbetter; Jonathan Flint

Telomere-specific clones are a valuable resource for the characterization of chromosomal rearrangements. We previously reported a first-generation set of human telomere probes consisting of 34 genomic clones, which were a known distance from the end of the chromosome ( approximately 300 kb), and 7 clones corresponding to the most distal markers on the integrated genetic/physical map (1p, 5p, 6p, 9p, 12p, 15q, and 20q). Subsequently, this resource has been optimized and completed: the size of the genomic clones has been expanded to a target size of 100-200 kb, which is optimal for use in genome-scanning methodologies, and additional probes for the remaining seven telomeres have been identified. For each clone we give an associated mapped sequence-tagged site and provide distances from the telomere estimated using a combination of fiberFISH, interphase FISH, sequence analysis, and radiation-hybrid mapping. This updated set of telomeric clones is an invaluable resource for clinical diagnosis and represents an important contribution to genetic and physical mapping efforts aimed at telomeric regions.


Journal of Medical Genetics | 2001

Clinical studies on submicroscopic subtelomeric rearrangements: a checklist

B. de Vries; Susan M. White; Samantha J. L. Knight; Regina Regan; Tessa Homfray; I Young; Maurice Super; Craig A. McKeown; Miranda Splitt; O W J Quarrell; Ah Trainer; M. F. Niermeijer; Sue Malcolm; J Flint; Jane A. Hurst; Robin M. Winter

BACKGROUND Submicroscopic subtelomeric chromosome defects have been found in 7.4% of children with moderate to severe mental retardation and in 0.5% of children with mild retardation. Effective clinical preselection is essential because of the technical complexities and cost of screening for subtelomere deletions. METHODS We studied 29 patients with a known subtelomeric defect and assessed clinical variables concerning birth history, facial dysmorphism, congenital malformations, and family history. Controls were 110 children with mental retardation of unknown aetiology with normal G banded karyotype and no detectable submicroscopic subtelomeric abnormalities. RESULTS Prenatal onset of growth retardation was found in 37% compared to 9% of the controls (p<0.0005). A higher percentage of positive family history for mental retardation was reported in the study group than the controls (50%v 21%, p=0.002). Miscarriage(s) were observed in only 8% of the mothers of subtelomeric cases compared to 30% of controls (p=0.028) which was, however, not significant after a Bonferroni correction. Common features (>30%) among subtelomeric deletion cases were microcephaly, short stature, hypertelorism, nasal and ear anomalies, hand anomalies, and cryptorchidism. Two or more facial dysmorphic features were observed in 83% of the subtelomere patients. None of these features was significantly different from the controls. Using the results, a five item checklist was developed which allowed exclusion from further testing in 20% of the mentally retarded children (95% CI 13-28%) in our study without missing any subtelomere cases. As our control group was selected for the “chromosomal phenotype”, the specificity of the checklist is likely to be higher in an unselected group of mentally retarded subjects. CONCLUSIONS Our results suggest that good indicators for subtelomeric defects are prenatal onset of growth retardation and a positive family history for mental retardation. These clinical criteria, in addition to features suggestive of a chromosomal phenotype, resulted in the development of a five item checklist which will improve the diagnostic pick up rate of subtelomeric defects among mentally retarded subjects.


Journal of Medical Genetics | 2000

Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis

Samantha J. L. Knight; Jonathan Flint

Chromosomal rearrangements involving the ends of chromosomes (telomeres) are emerging as an important cause of human genetic diseases. This review describes the development of first and second generation sets of telomere specific clones, together with advances in fluorescence in situ hybridisation (FISH) technology, which have made the prospect of screening for telomeric rearrangements a realistic goal. Initial FISH studies using the telomere specific clones indicate that they will be a valuable diagnostic tool for the investigation of mental retardation, the characterisation of known abnormalities detected by conventional cytogenetic analysis, spontaneous recurrent miscarriages, infertility, haematological malignancies, and preimplantation diagnosis, as well as other fields of clinical interest. In addition, they may help investigate telomere structure and function and can be used in the identification of dosage sensitive genes involved in human genetic disease.

Collaboration


Dive into the Samantha J. L. Knight's collaboration.

Top Co-Authors

Avatar

Jenny C. Taylor

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar

Regina Regan

University College Dublin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jonathan Flint

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge